Insider Transactions in Q2 2021 at Evolent Health, Inc. (EVH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.52%
|
$380,000
$19.7 P/Share
|
|
Jun 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.5%
|
$30,000
$3.84 P/Share
|
|
Jun 11
2021
|
Cheryl Scott Director |
SELL
Open market or private sale
|
Direct |
6,405
-11.64%
|
$121,695
$19.39 P/Share
|
|
Jun 10
2021
|
Mary Bridget Duffy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+12.94%
|
-
|
|
Jun 10
2021
|
David Farner Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+11.23%
|
-
|
|
Jun 10
2021
|
Cheryl Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+12.39%
|
-
|
|
Jun 10
2021
|
Diane Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+11.23%
|
-
|
|
Jun 10
2021
|
Peter J Grua Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+19.92%
|
-
|
|
Jun 10
2021
|
Michael D'Amato Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+7.69%
|
-
|
|
Jun 10
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+42.21%
|
-
|
|
Jun 10
2021
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+40.09%
|
-
|
|
Jun 10
2021
|
Frank J Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,785
+1.17%
|
-
|
|
May 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.5%
|
$380,000
$19.73 P/Share
|
|
May 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.47%
|
$30,000
$3.84 P/Share
|
|
May 04
2021
|
Jonathan Weinberg General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-17.89%
|
$420,000
$21.37 P/Share
|
|
May 04
2021
|
Jonathan Weinberg General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.18%
|
$60,000
$3.84 P/Share
|
|
May 03
2021
|
Steve Tutewohl Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,295
-7.8%
|
$405,195
$21.49 P/Share
|
|
May 03
2021
|
Steve Tutewohl Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,352
+7.04%
|
$65,464
$7.83 P/Share
|